CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Astria Therapeutics, Inc. - ATXS CFD

    -
    0%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread -
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* N/A
    Open* N/A
    1-Year Change* N/A
    Day's Range* N/A
    52 wk Range 2.36-16.28
    Average Volume (10 days) 239.64K
    Average Volume (3 months) 4.84M
    Market Cap 372.22M
    P/E Ratio -100.00K
    Shares Outstanding 27.99M
    Revenue N/A
    EPS -3.62
    Dividend (Yield %) N/A
    Beta 0.91
    Next Earnings Date May 10, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low

    Astria Therapeutics, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0
    Total Operating Expense 53.503 194.976 37.435 27.088 26.371
    Selling/General/Admin. Expenses, Total 19.239 14.807 11.845 8.771 9.329
    Research & Development 34.264 180.169 25.59 18.317 17.042
    Operating Income -53.503 -194.976 -37.435 -27.088 -26.371
    Interest Income (Expense), Net Non-Operating 1.724 0.122 0.236 0.845 0.325
    Other, Net -0.055 -0.058 -0.101 -0.05 0.176
    Net Income Before Taxes -51.834 -194.912 -37.3 -26.293 -25.87
    Net Income After Taxes -51.834 -194.912 -37.3 -26.293 -25.87
    Net Income Before Extra. Items -51.834 -194.912 -37.3 -26.293 -25.87
    Net Income -51.834 -194.912 -37.3 -26.293 -25.87
    Income Available to Common Excl. Extra. Items -51.834 -219.349 -37.3 -26.293 -25.87
    Income Available to Common Incl. Extra. Items -51.834 -219.349 -37.3 -26.293 -25.87
    Diluted Net Income -51.834 -219.349 -37.3 -26.293 -25.87
    Diluted Weighted Average Shares 14.6206 8.92517 3.05864 1.86655 0.84249
    Diluted EPS Excluding Extraordinary Items -3.54527 -24.5764 -12.195 -14.0864 -30.7067
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -3.54527 -24.5764 -12.195 -14.0864 -30.7067
    Revenue 0
    Total Extraordinary Items
    Total Adjustments to Net Income 0 -24.437
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 0 0 0 0 0
    Total Operating Expense 14.29 12.386 11.449 15.378 9.508
    Selling/General/Admin. Expenses, Total 4.699 4.688 4.832 5.02 3.815
    Research & Development 9.591 7.698 6.617 10.358 5.693
    Operating Income -14.29 -12.386 -11.449 -15.378 -9.508
    Other, Net 0.009 -0.048 -0.015 -0.001 -0.016
    Net Income Before Taxes -13.263 -11.997 -11.25 -15.323 -9.491
    Net Income After Taxes -13.263 -11.997 -11.25 -15.323 -9.491
    Net Income Before Extra. Items -13.263 -11.997 -11.25 -15.323 -9.491
    Net Income -13.263 -11.997 -11.25 -15.323 -9.491
    Income Available to Common Excl. Extra. Items -13.263 -11.997 -11.25 -15.323 -9.491
    Income Available to Common Incl. Extra. Items -13.263 -11.997 -11.25 -15.323 -9.491
    Diluted Net Income -13.263 -11.997 -11.25 -15.323 -9.491
    Diluted Weighted Average Shares 18.6982 13.7424 13.017 13.017 13.0598
    Diluted EPS Excluding Extraordinary Items -0.70932 -0.87299 -0.86426 -1.17716 -0.72673
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -0.70932 -0.87299 -0.86426 -1.17716 -0.72673
    Interest Income (Expense), Net Non-Operating 1.018 0.437 0.214 0.056 0.033
    Total Adjustments to Net Income 0 0 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 127.075 46.325 38.958 38.915 17.463
    Cash and Short Term Investments 125.508 44.93 36.244 37.57 16.369
    Cash & Equivalents 1.853 22.999 5.432 5.956 16.369
    Short Term Investments 39 20 26.345 22.276 0
    Prepaid Expenses 1.446 1.274 2.237 1.345 1.094
    Total Assets 127.514 47.456 41.78 39.169 17.897
    Property/Plant/Equipment, Total - Net 0.394 0.966 2.349 0.056 0.321
    Property/Plant/Equipment, Total - Gross 0.377
    Accumulated Depreciation, Total -0.321
    Other Long Term Assets, Total 0.045 0.165 0.473 0.198 0.113
    Total Current Liabilities 5.203 6.39 5.032 4.171 6.016
    Accounts Payable 1.557 1.544 1.197 1.408 0.773
    Accrued Expenses 3.646 4.846 3.835 2.763 2.432
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 2.479
    Total Liabilities 5.203 6.787 6.06 4.227 6.105
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt 0
    Other Liabilities, Total 0 0.397 1.028 0.056 0.089
    Total Equity 122.311 40.669 35.72 34.942 11.792
    Common Stock 0.013 0.02 0.012 0.007 0.024
    Additional Paid-In Capital 481.709 301.546 259.305 232.243 183.202
    Retained Earnings (Accumulated Deficit) -455.809 -260.897 -223.597 -197.304 -171.434
    Other Equity, Total 0 0 -0.004 0
    Total Liabilities & Shareholders’ Equity 127.514 47.456 41.78 39.169 17.897
    Total Common Shares Outstanding 13.017 3.34746 2.07227 0.11903 0.3941
    Other Current Liabilities, Total 0 0.332
    Preferred Stock - Non Redeemable, Net 96.398 0 0 0
    Cash 84.655 1.931 4.467 9.338
    Other Current Assets, Total 0.121 0.121 0.477
    Total Preferred Shares Outstanding 0.03146
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 114.221 127.075 134.522 140.052 147.684
    Cash and Short Term Investments 112.816 125.508 131.777 139.52 146.92
    Cash & Equivalents 46.687 86.508 131.777 139.52 146.92
    Short Term Investments 66.129 39 0 0 0
    Prepaid Expenses 1.121 1.446 2.624 0.411 0.643
    Other Current Assets, Total 0.284 0.121 0.121 0.121 0.121
    Total Assets 114.653 127.514 135.129 140.945 148.74
    Property/Plant/Equipment, Total - Net 0.228 0.394 0.557 0.717 0.874
    Other Long Term Assets, Total 0.204 0.045 0.05 0.176 0.182
    Total Current Liabilities 4.967 5.203 4.7 3.988 4.406
    Accounts Payable 0.931 1.557 0.574 0.619 1.809
    Accrued Expenses 4.036 3.646 4.126 3.369 2.597
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 4.967 5.203 4.7 4.046 9.004
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0 0 0.058 4.598
    Total Equity 109.686 122.311 130.429 136.899 139.736
    Preferred Stock - Non Redeemable, Net 96.398 96.398 96.398 99.77 240.881
    Common Stock 0.013 0.013 0.013 0.077 0.023
    Additional Paid-In Capital 484.46 481.709 480.336 475.499 329.813
    Retained Earnings (Accumulated Deficit) -471.132 -455.809 -446.318 -438.447 -430.981
    Total Liabilities & Shareholders’ Equity 114.653 127.514 135.129 140.945 148.74
    Total Common Shares Outstanding 13.017 13.017 13.0095 12.8248 3.90283
    Total Preferred Shares Outstanding 0.03146 0.03146 0.03146 0.03255
    Other Equity, Total -0.053 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -51.834 -194.912 -37.3 -26.293 -25.87
    Cash From Operating Activities -43.533 -30.151 -32.485 -26.569 -23.465
    Cash From Operating Activities 0.026 0.119
    Non-Cash Items 5.654 168.066 1.448 1.568 1.524
    Cash Interest Paid 0 0.079
    Changes in Working Capital 2.647 -3.305 3.367 -1.87 0.762
    Cash From Investing Activities -167.129 -12.555 6.3 -4.082 -21.905
    Capital Expenditures -0.091 -0.021 -0.033 -0.012 0
    Other Investing Cash Flow Items, Total -167.038 -12.534 6.333 -4.07 -21.905
    Cash From Financing Activities 144.721 104.284 40.86 25.62 44.295
    Issuance (Retirement) of Stock, Net 144.721 104.284 40.86 25.62 47.143
    Issuance (Retirement) of Debt, Net 0 -2.848
    Net Change in Cash -65.941 61.578 14.675 -5.031 -1.075
    Financing Cash Flow Items
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -51.834 -38.571 -26.574 -15.323 -194.912
    Cash From Operating Activities -43.533 -32.869 -22.62 -12.559 -30.151
    Non-Cash Items 5.654 5.15 3.947 2.672 168.066
    Changes in Working Capital 2.647 0.552 0.007 0.092 -3.305
    Cash From Investing Activities -167.129 -31.949 -33.899 -27.099 -12.555
    Capital Expenditures -0.091 -0.06 -0.002 0 -0.021
    Other Investing Cash Flow Items, Total -167.038 -31.889 -33.897 -27.099 -12.534
    Cash From Financing Activities 144.721 24.324 0 0 104.284
    Issuance (Retirement) of Stock, Net 144.721 24.324 0 0 104.284
    Net Change in Cash -65.941 -40.494 -56.519 -39.658 61.578
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fidelity Management & Research Company LLC Investment Advisor 11.9754 3351514 2974069 2022-12-31 LOW
    Perceptive Advisors LLC Private Equity 7.8232 2189462 908265 2022-12-31 MED
    Fairmount Funds Management LLC Hedge Fund 6.7939 1901397 989661 2022-12-31 HIGH
    Deep Track Capital LP Hedge Fund 6.4907 1816531 1816531 2022-12-31 MED
    Vivo Capital, LLC Venture Capital 6.0071 1681199 681199 2022-12-31 MED
    Cormorant Asset Management, LP Hedge Fund 5.8957 1650000 450000 2022-12-31 MED
    Altium Capital Management LP Investment Advisor/Hedge Fund 4.8429 1355372 910372 2022-12-31 HIGH
    Driehaus Capital Management, LLC Investment Advisor/Hedge Fund 4.7784 1337315 680954 2022-12-31 MED
    Logos Global Management LLC Investment Advisor 3.0906 864960 864960 2022-12-31 HIGH
    Ikarian Capital LLC Hedge Fund 2.4125 675176 -24264 2022-12-31 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.338 654326 123173 2022-12-31 LOW
    Rosalind Advisors, Inc. Hedge Fund 2.3348 653438 653438 2021-12-31 LOW
    Tri Locum Partners LP Hedge Fund 2.3273 651330 19751 2022-12-31 HIGH
    Affinity Asset Advisors LLC Hedge Fund 1.6882 472482 72439 2022-12-31 HIGH
    Sphera Funds Management Ltd. Hedge Fund 1.677 469340 469340 2022-12-31 MED
    Ghost Tree Capital, LLC Hedge Fund 1.6079 450000 -50000 2022-12-31 HIGH
    Violin (Jonathan) Individual Investor 0.9409 263321 0 2022-04-13 LOW
    Opaleye Management Inc. Hedge Fund 0.9351 261703 128203 2022-12-31 MED
    Medical Strategy GmbH Investment Advisor 0.9026 252605 -18814 2022-09-30 LOW
    Point72 Asset Management, L.P. Hedge Fund 0.804 225000 225000 2022-12-31 HIGH

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Bio Therapeutic Drugs

    75 State Street
    Suite 1400
    BOSTON
    MASSACHUSETTS 02109
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    BTC/USD

    28,392.85 Price
    -0.260% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Biaya inap posisi Long -0.4092%
    Biaya inap posisi short 0.3873%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.005

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Biaya inap posisi Long -0.0156%
    Biaya inap posisi short -0.0063%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda